Welcome to our dedicated page for Becton Dickinson & Co SEC filings (Ticker: BDX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Becton, Dickinson and Company (BD) SEC filings page for ticker BDX provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a New Jersey–incorporated issuer with common stock listed on the New York Stock Exchange, BD files current reports on Form 8-K, annual and quarterly reports, proxy statements and other documents that give investors insight into its financial condition, governance and capital structure.
BD’s recent Form 8-K filings include disclosures on financial results, such as preliminary unaudited revenue and quarterly earnings press releases, as well as corporate events like executive transitions, board appointments and changes in credit facilities. For example, BD has reported the appointment of new directors, the planned transition of its chief financial officer role, and the execution of a third amended and restated revolving credit agreement that provides senior unsecured financing for general corporate purposes. Other 8-K filings describe temporary blackout periods under the BD 401(k) Plan related to a transaction involving Waters Corporation.
Investors can also review BD’s definitive proxy statement on Schedule 14A, which outlines matters for shareholder voting, board composition, executive compensation programs and strategic themes such as the BD2025 and Excellence Unleashed strategies. Debt-related filings, including listings of various series of notes and a Form 25 relating to the removal from listing of 0.034% Notes due 2025, help users understand BD’s capital markets activities. Common stock and several note issues remain registered and listed on the NYSE, as indicated in the filings.
On this page, Stock Titan presents BD’s SEC filings alongside AI-powered summaries that highlight key points from lengthy documents, such as 10-K and 10-Q reports, 8-K event descriptions and proxy materials. Users can quickly identify information about BD’s revolving credit facilities, leverage covenants, executive changes, shareholder meetings and note listings, while still having the option to review the full original filings from EDGAR for detailed analysis.
Becton Dickinson & Co. is reported as having 21,397,756 shares beneficially owned by Vanguard Capital Management as of 03/31/2026, equal to 7.51% of common stock. Vanguard Capital Management discloses sole dispositive power over 21,397,756 shares and sole voting power over 2,907,146 shares. The filing states these holdings include securities held for Vanguard funds and other managed accounts; no single other person is reported to hold more than 5% of the class.
Becton, Dickinson and Company reported that its Board of Directors approved an amended and restated version of the company’s By-laws on April 28, 2026. The key change updates the advance notice provision that is used to determine when a director election is considered contested.
The revisions also include other technical, conforming and clarifying updates to the By-laws. The full amended By-laws are provided as Exhibit 3.1 to this report and are incorporated by reference for a complete description of the changes.
Becton Dickinson & Co ownership filing: Vanguard Portfolio Management reports beneficial ownership of 15,388,359 shares of Common Stock, representing 5.4% of the class as of 03/31/2026. The filing shows sole voting power for 71,117 shares and sole dispositive power for 15,388,359 shares. The filing is signed on 04/29/2026 by Ashley Grim.
Becton Dickinson & Co executive Michael Feld, EVP and Chief Revenue Officer, reported an open-market sale of 74 shares of Common Stock at $151.94 per share. After this transaction, he directly holds 21,159 shares of Becton Dickinson common stock, according to the filing.
Becton, Dickinson and Company notice of proposed sale of common stock under Rule 144/Section 5, identifying restricted stock units and prior 10b5-1 sales by Michael Feld. The filing lists 74 Restricted Stock Units with an 08/20/2025 date and two reported 10b5-1 sales of 75 shares on 02/26/2026 and 03/26/2026.
Becton, Dickinson and Company announced that Richard (Rick) Byrd, executive vice president and president of the Interventional segment, has informed the company of his intention to retire after nearly 25 years with BD. He has led the Interventional segment since September 2022 and previously held several other leadership roles.
Byrd will remain in his current position through June, providing time for an orderly transition, and BD intends to name a successor before his retirement date. The company also issued a press release describing his contributions across multiple segments and his role during the COVID-19 pandemic.
Becton, Dickinson and Company announced that Richard (Rick) Byrd, executive vice president and president of the Interventional segment, has informed the company of his intention to retire after nearly 25 years with BD. He has led the Interventional segment since September 2022 and previously held several other leadership roles.
Byrd will remain in his current position through June, providing time for an orderly transition, and BD intends to name a successor before his retirement date. The company also issued a press release describing his contributions across multiple segments and his role during the COVID-19 pandemic.
Becton, Dickinson and Company announced that Richard (Rick) Byrd, executive vice president and president of the Interventional segment, has informed the company of his intention to retire after nearly 25 years with BD. He has led the Interventional segment since September 2022 and previously held several other leadership roles.
Byrd will remain in his current position through June, providing time for an orderly transition, and BD intends to name a successor before his retirement date. The company also issued a press release describing his contributions across multiple segments and his role during the COVID-19 pandemic.
Becton Dickinson & Co executive Neal Shana Carol reported a tax-related share withholding tied to equity compensation. On this Form 4, 1,146 shares of common stock were withheld to cover withholding taxes upon vesting of previously granted restricted stock units. After this non-market disposition, Carol directly holds 23,966 common shares. The filing also notes that direct holdings reflect adjustments connected to the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp., which affected the number of shares underlying previously reported unvested time-based restricted stock units.
Becton, Dickinson and Company has recast its historical financial statements to reflect the February 9, 2026 spin-off and combination of its Biosciences and Diagnostic Solutions business with Waters Corporation. The recast data present BD as a standalone company, treating that business as discontinued operations.
For the twelve months ended September 30, 2025, BD reported revenues of $18,544 million and net income from continuing operations of $1,100 million, with diluted earnings per share from continuing operations of $3.81, compared with $16,820 million, $1,054 million and $3.62 in 2024. BD also provides non-GAAP measures that adjust for purchase accounting, integration and restructuring costs, separation-related items, certain regulatory and legal costs, and related tax effects to highlight underlying operating performance.
Becton Dickinson & Co executive Michael Feld, EVP and Chief Revenue Officer, sold 75 shares of common stock at $156.83 per share in an open-market transaction executed under a Rule 10b5-1 trading plan. After this planned sale, he directly owns 21,233 shares.
Michael Feld reports proposed and completed sales of Common Stock. The filing lists a proposed sale of 75 Restricted Stock Units to be sold through the issuer on 08/20/2025. It also records two 10b5-1 sales by Michael Feld of 75 shares each on 02/26/2026 and 01/26/2026 with amounts shown as 13638.00 and 15204.75, respectively.
The broker listed is Morgan Stanley Smith Barney LLC at New York Plaza. The filing is a routine notice of sale under Form 144 and documents the seller, security type, sale dates, and per-sale amounts as provided.